Drug: TRUVADA Injury: Immune reconstitution inflammatory syndrome Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124472542 | TRUVADA | Immune reconstitution inflammatory syndrome | VIIV | 40.00 YR | M | 0 | 20160726 | JP |
124511212 | TRUVADA | Immune reconstitution inflammatory syndrome | VIIV | 49.33 YR | M | 0 | 20160705 | JP |
125534381 | TRUVADA | Immune reconstitution inflammatory syndrome | GILEAD | 34.00 YR | M | 0 | 20160713 | FR |
125697023 | TRUVADA | Immune reconstitution inflammatory syndrome | VIIV | 0.00 | M | 0 | 20160907 | JP |
126668391 | TRUVADA | Immune reconstitution inflammatory syndrome | BRISTOL MYERS SQUIBB | 34.00 YR | M | 0 | 20160819 | FR |
126952691 | TRUVADA | Immune reconstitution inflammatory syndrome | GILEAD | 49.00 YR | M | 0 | 20160829 | JP |
Total Records: 6 Number of Pages: 1